[Form 4] INTUITIVE SURGICAL INC Insider Trading Activity

Rhea-AI Filing Summary

Intuitive Surgical EVP & Chief Medical Officer Myriam Curet reported option and stock transactions plus performance stock units. On January 29, 2026, she exercised 126 non-qualified stock options at $208.9 per share and sold 126 common shares at $520.02 per share under a Rule 10b5-1 trading plan that expires July 29, 2026.

Following these trades, she reported no directly held common stock and 353 common shares held indirectly through a trust. Separately, on January 28, 2026, 5,585 performance stock units granted on February 28, 2023 were reported after the company confirmed performance goals were achieved; these PSUs are scheduled to vest on February 28, 2026, subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		M(1)		126	A	$208.9	126	D
Common Stock	01/29/2026		S(1)		126	D	$520.02	0	D
Common Stock								353	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$208.9	01/29/2026		M(1)			126	(2)	08/28/2029	Common Stock	126	$0.0	125	D
Performance Stock Units - 2-28-2023	$0.0	01/28/2026		A		5,585		(3)	(3)	Common Stock	5,585	$0.0	5,585	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

3. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ISRG executive Myriam Curet report?

Myriam Curet reported an option exercise and stock sale. On January 29, 2026, she exercised 126 options at $208.9 per share and sold 126 Intuitive Surgical common shares at $520.02 per share under a pre-arranged Rule 10b5-1 trading plan.

How many Intuitive Surgical shares does Myriam Curet hold after this Form 4?

After the reported transactions, Curet shows no directly held common shares. The filing lists 353 Intuitive Surgical common shares held indirectly through a trust, reflecting her remaining reported equity exposure outside of derivative awards and performance stock units.

What are the details of Myriam Curet’s option exercise in ISRG stock?

Curet exercised 126 non-qualified stock options. The options had a $208.9 exercise price per share and were granted under the 2010 Incentive Award Plan, with monthly vesting terms as described, and 125 derivative option units remained beneficially owned after the transaction.

At what price did Myriam Curet sell Intuitive Surgical shares?

She sold 126 common shares at $520.02 per share. The sale occurred on January 29, 2026 and was executed pursuant to a Rule 10b5-1 trading plan, which is scheduled to remain in effect until July 29, 2026 according to the disclosure.

What performance stock units did Myriam Curet report for ISRG?

Curet reported 5,585 performance stock units (PSUs). These PSUs were originally granted on February 28, 2023. The compensation committee confirmed performance goals were achieved, and the PSUs are scheduled to vest on February 28, 2026, assuming her continuous service through that date.

Is Myriam Curet’s Intuitive Surgical trading under a Rule 10b5-1 plan?

Yes, the filing states the transactions follow a Rule 10b5-1 trading plan. The plan is described as compliant with SEC Rule 10b5-1 and is scheduled to expire on July 29, 2026, providing a pre-arranged framework for executing trades.